Register entryRepackager / relabeller
- Registered sites
- 1
- Active NDC listings
- 61
- Labeller names
- 2
- Live patents
- 0
- Countries
- 1
- Base
- United States
Authorisation
Registered operations
Relabelling1Repackaging1
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| PHOENIX RX LLC | 390 LINCOLN AVE STE B, HATBORO, Pennsylvania (PA) 19040, United States (USA) | Relabelling, Repackaging | 3038222710119482401 |
Catalogue
Drug listings by form and route
6161 active NDC listings: 61 human prescription drug. By marketing category: ANDA 57, NDA AUTHORIZED GENERIC 3, UNAPPROVED DRUG OTHER 1.
| Dosage form | NDCs |
|---|---|
| tablet | 15 |
| tablet, film coated | 13 |
| tablet, delayed release | 8 |
| solution | 6 |
| capsule | 5 |
| ointment | 4 |
| patch | 3 |
| capsule, delayed release | 2 |
| capsule, extended release | 2 |
| gel | 1 |
| system | 1 |
| tablet, coated | 1 |
| Route | NDCs |
|---|---|
| oral | 46 |
| topical | 13 |
| cutaneous | 1 |
| transdermal | 1 |
| Labeller name on the listing | NDCs |
|---|---|
| phoenix rx llc | 59 |
| phoenix rx llc | 2 |
Catalogue
Marketed products
61| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Baclofen | Baclofen | tablet, oral | 85509-1344ANDA |
| CELECOXIB | CELECOXIB | capsule, oral | 85509-1237ANDA |
| CYCLOBENZAPRINE HYDROCHLORIDE | cyclobenzaprine hydrochloride | tablet, film coated, oral | 85509-1014ANDA |
| Celecoxib | Celecoxib | capsule, oral | 85509-1158ANDA |
| Cyclobenzaprine HCL | Cyclobenzaprine HCL | tablet, film coated, oral | 85509-1001ANDA |
| Cyclobenzaprine Hydrochloride | Cyclobenzaprine Hydrochloride | capsule, extended release, oral | 85509-1035ANDA |
| Cyclobenzaprine Hydrochloride | Cyclobenzaprine Hydrochloride | capsule, extended release, oral | 85509-1920NDA AUTHORIZED GENERIC |
| Cyclobenzaprine hydrochloride | Cyclobenzaprine hydrochloride | tablet, film coated, oral | 85509-1415ANDA |
| Diclofenac Epolamine | Diclofenac Epolamine | system, topical | 85509-1405NDA AUTHORIZED GENERIC |
| Diclofenac Potassium | diclofenac potassium | tablet, film coated, oral | 85509-1900ANDA |
| Diclofenac Potassium | diclofenac potassium | tablet, film coated, oral | 85509-2750ANDA |
| Diclofenac Sodium | Diclofenac Sodium | tablet, delayed release, oral | 85509-1201ANDA |
| Diclofenac Sodium | Diclofenac Sodium | solution, topical | 85509-1369ANDA |
| Diclofenac Sodium | Diclofenac Sodium | solution, topical | 85509-1406ANDA |
| Diclofenac Sodium | Diclofenac Sodium | solution, topical | 85509-1537ANDA |
| Diclofenac Sodium | Diclofenac Sodium Topical | gel, topical | 85509-1581ANDA |
| Diclofenac Sodium | Diclofenac | solution, topical | 85509-1911ANDA |
| Diclofenac Sodium | Diclofenac Sodium | solution, topical | 85509-2406ANDA |
| Diclofenac Sodium 1.5% | Diclofenac Sodium Topical | solution, topical | 85509-1038ANDA |
| Diclofenac Sodium Delayed Release | Diclofenac Sodium | tablet, delayed release, oral | 85509-1103ANDA |
| GABAPENTIN | Gabapentin | tablet, oral | 85509-1166ANDA |
| Gabapentin | Gabapentin | capsule, oral | 85509-2180ANDA |
| IBUPROFEN AND FAMOTIDINE | Ibuprofen and famotidine | tablet, oral | 85509-1315ANDA |
| Ibuprofen | Ibuprofen | tablet, oral | 85509-1466ANDA |
| Ibuprofen | Ibuprofen | tablet, film coated, oral | 85509-2396ANDA |
| Ibuprofen and famotidine | Ibuprofen and famotidine | tablet, film coated, oral | 85509-1010ANDA |
| Ibuprofen and famotidine | Ibuprofen and famotidine | tablet, film coated, oral | 85509-1626ANDA |
| LIDOCAINE | LIDOCAINE | ointment, topical | 85509-1424ANDA |
| Lidocaine | Lidocaine | patch, topical | 85509-1791ANDA |
| Lidocaine | Lidocaine | ointment, topical | 85509-1918ANDA |
| Lidocaine | lidocaine | patch, cutaneous | 85509-2880NDA AUTHORIZED GENERIC |
| Lidocaine | Lidocaine | ointment, topical | 85509-3008ANDA |
| MELOXICAM | meloxicam | tablet, oral | 85509-1159ANDA |
| METHYLPREDNISOLONE | METHYLPREDNISOLONE | tablet, oral | 85509-1400ANDA |
| Metaxalone | Metaxalone | tablet, oral | 85509-1435ANDA |
| Metaxalone | Metaxalone | tablet, oral | 85509-2341ANDA |
| Methocarbamol | Methocarbamol | tablet, film coated, oral | 85509-1341ANDA |
| Methocarbamol | Methocarbamol Tablets | tablet, coated, oral | 85509-1770ANDA |
| Methocarbamol | methocarbamol | tablet, oral | 85509-1910ANDA |
| Methocarbamol | methocarbamol | tablet, oral | 85509-2910ANDA |
| Naproxen | Naproxen | tablet, oral | 85509-1436ANDA |
| Naproxen and esomeprazole magnesium | Naproxen and esomeprazole magnesium | tablet, delayed release, oral | 85509-1202ANDA |
| Naproxen and esomeprazole magnesium | Naproxen and esomeprazole magnesium | tablet, delayed release, oral | 85509-1203ANDA |
| Naproxen and esomeprazole magnesium | Naproxen and esomeprazole magnesium | tablet, delayed release, oral | 85509-1438ANDA |
| Naproxen sodium | Naproxen sodium | tablet, film coated, oral | 85509-1495ANDA |
| Omeprazole | Omeprazole | capsule, delayed release, oral | 85509-1396ANDA |
| Omeprazole | Omeprazole | capsule, delayed release, oral | 85509-1644ANDA |
| Omeprazole and Sodium Bicarbonate | Omeprazole and Sodium Bicarbonate | capsule, oral | 85509-1031ANDA |
| Omeprazole and Sodium Bicarbonate | Omeprazole and Sodium Bicarbonate | capsule, oral | 85509-1032ANDA |
| Ondansetron Hydrochloride | Ondansetron Hydrochloride | tablet, film coated, oral | 85509-1057ANDA |
| Ondansetron Hydrochloride | Ondansetron Hydrochloride | tablet, film coated, oral | 85509-1075ANDA |
| Ondansetron Hydrochloride | Ondansetron Hydrochloride | tablet, film coated, oral | 85509-1076ANDA |
| Pantoprazole | Pantoprazole | tablet, delayed release, oral | 85509-1332ANDA |
| Pantoprazole Sodium | Pantoprazole | tablet, delayed release, oral | 85509-1636ANDA |
| Rabeprazole Sodium | Rabeprazole Sodium | tablet, delayed release, oral | 85509-1443ANDA |
| Tizanidine | Tizanidine | tablet, oral | 85509-1180ANDA |
| Trubrexa | lidocaine and capsaicin | patch, transdermal | 85509-4000UNAPPROVED DRUG OTHER |
| lidocaine | lidocaine | ointment, topical | 85509-1418ANDA |
| meloxicam | meloxicam | tablet, oral | 85509-1051ANDA |
| meloxicam | meloxicam | tablet, oral | 85509-1124ANDA |
| meloxicam | meloxicam | tablet, oral | 85509-1125ANDA |
Compare
Comparable companies in United States
- Bryant Ranch Prepack1 site · 4,357 NDC
- Proficient Rx LP1 site · 1,729 NDC
- RemedyRepack, Inc1 site · 1,521 NDC
- Preferred Pharmaceuticals Inc.1 site · 1,046 NDC
- PD-Rx Pharmaceuticals Inc.1 site · 828 NDC
- Camber Pharmaceuticals, Inc.1 site · 640 NDC
- Northwind Health Company, LLC1 site · 580 NDC
- Direct Rx1 site · 554 NDC
- Professional Compounding Centers of America dba PCCA1 site · 487 NDC
- Coupler LLC1 site · 469 NDC
Enquiry
Common questions
- Is PHOENIX RX LLC FDA approved?
- PHOENIX RX LLC holds 1 FDA-registered establishment in the United States. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are PHOENIX RX LLC's registered sites?
- The FDA register lists HATBORO, PA. Registered operations: relabelling, repackaging.
- What drugs does PHOENIX RX LLC make?
- 61 products are listed under PHOENIX RX LLC in the openFDA NDC Directory, most often as tablet; tablet, film coated; tablet, delayed release. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.